These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24352695)

  • 41. Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer.
    Lu L; Katsaros D; Mayne ST; Risch HA; Benedetto C; Canuto EM; Yu H
    Carcinogenesis; 2012 Nov; 33(11):2119-25. PubMed ID: 22822098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations of IL-27 polymorphisms and serum IL-27p28 levels with osteosarcoma risk.
    Tang YJ; Wang JL; Nong LG; Lan CG; Zha ZG; Liao PH
    Medicine (Baltimore); 2014 Aug; 93(10):e56. PubMed ID: 25170932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
    Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
    Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers.
    Bhaskari J; Premalata CS; Shilpa V; Rahul B; Pallavi VR; Ramesh G; Krishnamoorthy L
    Tumour Biol; 2016 Jan; 37(1):1017-23. PubMed ID: 26264619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients.
    Zhang S; Hou X; Zi S; Wang Y; Chen L; Kong B
    Cell Physiol Biochem; 2013; 31(4-5):525-31. PubMed ID: 23571222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery.
    Hosono S; Kajiyama H; Mizuno K; Sakakibara K; Matsuzawa K; Takeda A; Kawai M; Nagasaka T; Kikkawa F
    Int J Clin Oncol; 2011 Oct; 16(5):524-32. PubMed ID: 21431342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
    Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
    J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between IL-27 Gene Polymorphisms and Cancer Susceptibility in Asian Population: A Meta-Analysis.
    Moazeni-Roodi A; Hashemi M; Ghavami S
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2507-2515. PubMed ID: 32986346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
    Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
    Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.
    Chen K; Ma H; Li L; Zang R; Wang C; Song F; Shi T; Yu D; Yang M; Xue W; Dai J; Li S; Zheng H; Wu C; Zhang Y; Wu X; Li D; Xue F; Li H; Jiang Z; Liu J; Liu Y; Li P; Tan W; Han J; Jie J; Hao Q; Hu Z; Lin D; Ma D; Jia W; Shen H; Wei Q
    Nat Commun; 2014 Aug; 5():4682. PubMed ID: 25134534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of IL-27 gene three polymorphisms with Crohn's disease susceptibility in a Chinese Han population.
    Wang Z; Wang L; Fan R; Zhou J; Zhong J
    Int J Clin Exp Pathol; 2014; 7(12):8952-7. PubMed ID: 25674271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer.
    Zhang Z; Zhou B; Zhang J; Chen Y; Lai T; Yan L; Liang A; Li Y; Wang Y; Chen Y; Zhang L; Xi MR
    Cancer Genet Cytogenet; 2010 Jan; 196(2):146-52. PubMed ID: 20082850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients.
    Tharwat E; Gad GFM; Nazmy MH; Mohamed HI; Hamza N; Wahid A; Ibrahim ARN
    Immunol Invest; 2019 Apr; 48(3):255-267. PubMed ID: 30204505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population.
    Janardhan B; Vaderhobli S; Bhagat R; Chennagiri Srinivasamurthy P; Venketeshiah Reddihalli P; Gawari R; Krishnamoorthy L
    PLoS One; 2015; 10(7):e0131190. PubMed ID: 26158818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?
    Chan JK; Loizzi V; Lin YG; Osann K; Brewster WR; DiSaia PJ
    Obstet Gynecol; 2003 Jul; 102(1):156-61. PubMed ID: 12850623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
    Polterauer S; Vergote I; Concin N; Braicu I; Chekerov R; Mahner S; Woelber L; Cadron I; Van Gorp T; Zeillinger R; Castillo-Tong DC; Sehouli J
    Int J Gynecol Cancer; 2012 Mar; 22(3):380-5. PubMed ID: 22266934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.
    Paulsen T; Kærn J; Tropé C
    Gynecol Oncol; 2011 Jul; 122(1):83-8. PubMed ID: 21435701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
    Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
    BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer.
    Bushley AW; Ferrell R; McDuffie K; Terada KY; Carney ME; Thompson PJ; Wilkens LR; Tung KH; Ness RB; Goodman MT
    Gynecol Oncol; 2004 Dec; 95(3):672-9. PubMed ID: 15581980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.